Pancreatic Cancer Research

ResearcherShanxi Medical UniversityActive in the last 2 years

Zhigang Wei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0777-9817; OpenAlex author ID A5049806537. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper

Papers 4

  1. DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis. Co-author DOI 10.1016/j.cca.2024.120080↗
  2. PDO-Based Drug Screening in Advanced Pancreatic Cancer Last author DOI 10.1053/j.gastro.2024.10.045↗
  3. Comprehensive analysis of disulfidptosis-related lncRNAs for predicting prognosis and response of immunotherapy in pancreatic adenocarcinoma. Last author DOI 10.21037/tcr-23-1706↗
  4. Exploration of Risk Factors for Pancreatic Cancer and Development of a Clinical High-Risk Group Rating Scale. Last author DOI 10.3390/jcm12010358↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chaojie Liang · 2 shared papers, 2024–2025 · strength 0.64
  2. Xiaowen Gong · 1 shared paper, 2025 · strength 0.28
  3. Junheng Guo · 1 shared paper, 2024 · strength 0.28
  4. Qian Zhao · 1 shared paper, 2023 · strength 0.20
  5. Yan Wang · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.